MarketPeel
Insider Trading Intelligence
Pricing
…
JS

Jay S. Stout

IMVT
CHIEF TECHNOLOGY OFFICER · IMMUNOVANT, INC. · CIK 0001702969
FILING MIX · LIFETIME31%/69%
BUYS
8
SELLS
18
TOTAL VALUE
$2.61M
COMPANIES
1
ACTIVE SINCE
Apr 2023
HOLDINGS NOW
218,408
AVG SELL PX
$30.24
TRADE KIND
SHOWING 26 / 26
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 34 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jay S. Stout, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+31.25%+3.05%+0.74%+2.31%+2.24%—
14d16+56.25%+3.38%+1.07%+2.31%+0.06%—
30d16+37.50%+3.66%+2.86%+1.64%+1.05%—
60d16+50.00%+7.30%+3.88%+3.42%-0.95%—
90d16(3 pending)+46.15%+5.43%+3.98%+1.45%-2.17%—
180d16(6 pending)+30.00%+14.72%+9.07%+5.65%-1.86%—
1y16(10 pending)+50.00%+10.87%+19.17%-8.30%-27.01%—
2y16(15 pending)+100.00%-0.76%+43.06%-43.82%-43.82%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IMVT · 218,408 shares · as of Jun 26, 2026
066,143132,286198,428264,571202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 18 sellsCOVERAGE · 13 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
33,277$38.18$1.27M218,408Jun 26, 2026Jun 26, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
6,723$38.94$261.8K211,685Jun 26, 2026Jun 26, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
2,754$29.62$81.6K251,685Apr 23, 2026Apr 24, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
8,614$24.83$213.9K255,957Apr 8, 2026Apr 10, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
1,518$24.83$37.7K254,439Apr 8, 2026Apr 10, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
66,937——264,571Apr 7, 2026Apr 9, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
96,851——96,851Apr 7, 2026Apr 9, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
1,977$26.03$51.5K197,634Jan 21, 2026Jan 23, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
1,148$26.51$30.4K199,666Jan 7, 2026Jan 9, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
55$26.92$1.5K199,611Jan 7, 2026Jan 9, 2026 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
2,520$19.03$48.0K200,814Oct 22, 2025Oct 24, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
1,585$16.30$25.8K203,334Oct 8, 2025Oct 10, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
2,805$18.15$50.9K204,919Jul 23, 2025Jul 25, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
1,519$17.24$26.2K207,724Jul 9, 2025Jul 11, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
1,925$14.79$28.5K209,243Apr 23, 2025Apr 25, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
5,004$12.99$65.0K211,168Apr 9, 2025Apr 11, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
76,181——216,172Apr 1, 2025Apr 3, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
107,297——107,297Apr 1, 2025Apr 3, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
2,195$23.59$51.8K139,991Jan 22, 2025Jan 24, 2025 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
2,740$29.53$80.9K142,186Oct 23, 2024Oct 25, 2024 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
2,813$27.76$78.1K144,926Jul 24, 2024Jul 26, 2024 ↗View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Technology Officer
7,239$28.90$209.2K147,739Apr 24, 2024Apr 26, 2024 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
68,723——68,723Apr 2, 2024Apr 4, 2024 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
54,978——154,978Apr 2, 2024Apr 4, 2024 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
100,000——100,000Apr 17, 2023Apr 19, 2023 ↗View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
150,000——150,000Apr 17, 2023Apr 19, 2023 ↗View →
Other insiders · IMVT
Loading peer insiders…
About this filer
CIK 0001702969
ROLE
Chief Technology Officer
PRIMARY
IMVT
COMPANIES
1
ACTIVE SINCE
Apr 2023
MARKETPEEL · /INSIDER/0001702969DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback